FMC Northern Georgia Inc in Canton, Georgia - Dialysis Center

FMC Northern Georgia Inc is a medicare approved dialysis facility center in Canton, Georgia and it has 14 dialysis stations. It is located in Cherokee county at 411 Hospital Road, Canton, GA, 30114. You can reach out to the office of FMC Northern Georgia Inc at (770) 479-0259. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC Northern Georgia Inc has the following ownership type - Profit. It was first certified by medicare in June, 1988. The medicare id for this facility is 112551 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameFMC Northern Georgia Inc
Location411 Hospital Road, Canton, Georgia
No. of Dialysis Stations 14
Medicare ID112551
Managed ByFresenius Medical Care
Ownership TypeProfit
Late Shifts No

Contact Information


411 Hospital Road, Canton, Georgia, 30114
(770) 479-0259
Not Available

News Archive

EHNAC announces second stage of public review and comment for its HIE Accreditation Program

The Electronic Healthcare Network Accreditation Commission, a non-profit standards development organization and accrediting body, today announced the second stage of public review and comment for its Health Information Exchange Accreditation Program. Compared to the first phase of the program's public review in February, which focused on privacy and security, technical performance, business practices and organizational resources, this second phase will explicitly address HIE-specific policies as developed by the HIE Advisory Board.

Life Technologies second-quarter Non-GAAP revenue increases 8% to $906 million

Life Technologies Corporation today announced results for its second quarter ending June 30, 2010. Non-GAAP revenue for the second quarter was $906 million, an increase of 8 percent over the $839 million reported for the second quarter of 2009. Excluding the impact of currency and prior acquisitions and divestitures, organic revenue for the quarter grew 6 percent over the same period in the previous year.

Olympic gold medal winner Lisa Leslie and Covidien launch new liver cancer education program

Four-time Olympic gold medal winner and three-time WNBA Most Valuable Player Lisa Leslie is teaming with Covidien, a leading global provider of healthcare products, to launch an educational program and Web site, www.MyLiverCancerOptions.com, that provide information to help patients and their families understand the treatment options available to manage liver cancer.

HeartWare International presents clinical trial data of Ventricular Assist System at ISHLT annual meeting

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that data from its international clinical trial and commercial experience of the HeartWare® Ventricular Assist System showed a survival rate of 90 percent at six months and an actuarial survival rate of 86 percent at 12 months post implant.

New blood test for diagnosing schizophrenia to be launched in 2010

A blood test for diagnosing schizophrenia - the most serious form of mental illness - could be available this year, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

Read more Medical News

› Verified 4 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with FMC Northern Georgia Inc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1871605600
Organization NameRcc Northern Georgia
Doing Business AsNational Medical Care, Inc.
Address411 Hospital Rd Canton, Georgia, 30114
Phone Number(770) 479-0259

News Archive

EHNAC announces second stage of public review and comment for its HIE Accreditation Program

The Electronic Healthcare Network Accreditation Commission, a non-profit standards development organization and accrediting body, today announced the second stage of public review and comment for its Health Information Exchange Accreditation Program. Compared to the first phase of the program's public review in February, which focused on privacy and security, technical performance, business practices and organizational resources, this second phase will explicitly address HIE-specific policies as developed by the HIE Advisory Board.

Life Technologies second-quarter Non-GAAP revenue increases 8% to $906 million

Life Technologies Corporation today announced results for its second quarter ending June 30, 2010. Non-GAAP revenue for the second quarter was $906 million, an increase of 8 percent over the $839 million reported for the second quarter of 2009. Excluding the impact of currency and prior acquisitions and divestitures, organic revenue for the quarter grew 6 percent over the same period in the previous year.

Olympic gold medal winner Lisa Leslie and Covidien launch new liver cancer education program

Four-time Olympic gold medal winner and three-time WNBA Most Valuable Player Lisa Leslie is teaming with Covidien, a leading global provider of healthcare products, to launch an educational program and Web site, www.MyLiverCancerOptions.com, that provide information to help patients and their families understand the treatment options available to manage liver cancer.

HeartWare International presents clinical trial data of Ventricular Assist System at ISHLT annual meeting

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that data from its international clinical trial and commercial experience of the HeartWare® Ventricular Assist System showed a survival rate of 90 percent at six months and an actuarial survival rate of 86 percent at 12 months post implant.

New blood test for diagnosing schizophrenia to be launched in 2010

A blood test for diagnosing schizophrenia - the most serious form of mental illness - could be available this year, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

Read more Medical News

› Verified 4 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data30

News Archive

EHNAC announces second stage of public review and comment for its HIE Accreditation Program

The Electronic Healthcare Network Accreditation Commission, a non-profit standards development organization and accrediting body, today announced the second stage of public review and comment for its Health Information Exchange Accreditation Program. Compared to the first phase of the program's public review in February, which focused on privacy and security, technical performance, business practices and organizational resources, this second phase will explicitly address HIE-specific policies as developed by the HIE Advisory Board.

Life Technologies second-quarter Non-GAAP revenue increases 8% to $906 million

Life Technologies Corporation today announced results for its second quarter ending June 30, 2010. Non-GAAP revenue for the second quarter was $906 million, an increase of 8 percent over the $839 million reported for the second quarter of 2009. Excluding the impact of currency and prior acquisitions and divestitures, organic revenue for the quarter grew 6 percent over the same period in the previous year.

Olympic gold medal winner Lisa Leslie and Covidien launch new liver cancer education program

Four-time Olympic gold medal winner and three-time WNBA Most Valuable Player Lisa Leslie is teaming with Covidien, a leading global provider of healthcare products, to launch an educational program and Web site, www.MyLiverCancerOptions.com, that provide information to help patients and their families understand the treatment options available to manage liver cancer.

HeartWare International presents clinical trial data of Ventricular Assist System at ISHLT annual meeting

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that data from its international clinical trial and commercial experience of the HeartWare® Ventricular Assist System showed a survival rate of 90 percent at six months and an actuarial survival rate of 86 percent at 12 months post implant.

New blood test for diagnosing schizophrenia to be launched in 2010

A blood test for diagnosing schizophrenia - the most serious form of mental illness - could be available this year, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

Read more Medical News

› Verified 4 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center46
    Adult patient months included in Kt/V greater than or equal to 1.2375
    Percentage of adult patients getting regular hemodialysis at the center
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    EHNAC announces second stage of public review and comment for its HIE Accreditation Program

    The Electronic Healthcare Network Accreditation Commission, a non-profit standards development organization and accrediting body, today announced the second stage of public review and comment for its Health Information Exchange Accreditation Program. Compared to the first phase of the program's public review in February, which focused on privacy and security, technical performance, business practices and organizational resources, this second phase will explicitly address HIE-specific policies as developed by the HIE Advisory Board.

    Life Technologies second-quarter Non-GAAP revenue increases 8% to $906 million

    Life Technologies Corporation today announced results for its second quarter ending June 30, 2010. Non-GAAP revenue for the second quarter was $906 million, an increase of 8 percent over the $839 million reported for the second quarter of 2009. Excluding the impact of currency and prior acquisitions and divestitures, organic revenue for the quarter grew 6 percent over the same period in the previous year.

    Olympic gold medal winner Lisa Leslie and Covidien launch new liver cancer education program

    Four-time Olympic gold medal winner and three-time WNBA Most Valuable Player Lisa Leslie is teaming with Covidien, a leading global provider of healthcare products, to launch an educational program and Web site, www.MyLiverCancerOptions.com, that provide information to help patients and their families understand the treatment options available to manage liver cancer.

    HeartWare International presents clinical trial data of Ventricular Assist System at ISHLT annual meeting

    HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that data from its international clinical trial and commercial experience of the HeartWare® Ventricular Assist System showed a survival rate of 90 percent at six months and an actuarial survival rate of 86 percent at 12 months post implant.

    New blood test for diagnosing schizophrenia to be launched in 2010

    A blood test for diagnosing schizophrenia - the most serious form of mental illness - could be available this year, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

    Read more Medical News

    › Verified 4 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center9
    Adult patient months included in Kt/V greater than or equal to 1.784
    Percentage of adult patients getting regular peritoneal dialysis at the center
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

    News Archive

    EHNAC announces second stage of public review and comment for its HIE Accreditation Program

    The Electronic Healthcare Network Accreditation Commission, a non-profit standards development organization and accrediting body, today announced the second stage of public review and comment for its Health Information Exchange Accreditation Program. Compared to the first phase of the program's public review in February, which focused on privacy and security, technical performance, business practices and organizational resources, this second phase will explicitly address HIE-specific policies as developed by the HIE Advisory Board.

    Life Technologies second-quarter Non-GAAP revenue increases 8% to $906 million

    Life Technologies Corporation today announced results for its second quarter ending June 30, 2010. Non-GAAP revenue for the second quarter was $906 million, an increase of 8 percent over the $839 million reported for the second quarter of 2009. Excluding the impact of currency and prior acquisitions and divestitures, organic revenue for the quarter grew 6 percent over the same period in the previous year.

    Olympic gold medal winner Lisa Leslie and Covidien launch new liver cancer education program

    Four-time Olympic gold medal winner and three-time WNBA Most Valuable Player Lisa Leslie is teaming with Covidien, a leading global provider of healthcare products, to launch an educational program and Web site, www.MyLiverCancerOptions.com, that provide information to help patients and their families understand the treatment options available to manage liver cancer.

    HeartWare International presents clinical trial data of Ventricular Assist System at ISHLT annual meeting

    HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that data from its international clinical trial and commercial experience of the HeartWare® Ventricular Assist System showed a survival rate of 90 percent at six months and an actuarial survival rate of 86 percent at 12 months post implant.

    New blood test for diagnosing schizophrenia to be launched in 2010

    A blood test for diagnosing schizophrenia - the most serious form of mental illness - could be available this year, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

    Read more Medical News

    › Verified 4 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC Northern Georgia Inc with elevated calcium levels.

Patients with hypercalcemia55
Hypercalcemia patient months490
Hypercalcemia patients with serumcalcium greater than 10.2 mg
Patients with Serumphosphor56
Patients with Serumphosphor less than 3.5 mg/dL
Patients with Serumphosphor from 3.5 to 4.5 mg/dL
Patients with Serumphosphor from 4.6 to 5.5 mg/dL
Patients with Serumphosphor from 5.6 to 7 mg/dL
Patients with Serumphosphor greater than 7 mg/dL

News Archive

EHNAC announces second stage of public review and comment for its HIE Accreditation Program

The Electronic Healthcare Network Accreditation Commission, a non-profit standards development organization and accrediting body, today announced the second stage of public review and comment for its Health Information Exchange Accreditation Program. Compared to the first phase of the program's public review in February, which focused on privacy and security, technical performance, business practices and organizational resources, this second phase will explicitly address HIE-specific policies as developed by the HIE Advisory Board.

Life Technologies second-quarter Non-GAAP revenue increases 8% to $906 million

Life Technologies Corporation today announced results for its second quarter ending June 30, 2010. Non-GAAP revenue for the second quarter was $906 million, an increase of 8 percent over the $839 million reported for the second quarter of 2009. Excluding the impact of currency and prior acquisitions and divestitures, organic revenue for the quarter grew 6 percent over the same period in the previous year.

Olympic gold medal winner Lisa Leslie and Covidien launch new liver cancer education program

Four-time Olympic gold medal winner and three-time WNBA Most Valuable Player Lisa Leslie is teaming with Covidien, a leading global provider of healthcare products, to launch an educational program and Web site, www.MyLiverCancerOptions.com, that provide information to help patients and their families understand the treatment options available to manage liver cancer.

HeartWare International presents clinical trial data of Ventricular Assist System at ISHLT annual meeting

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that data from its international clinical trial and commercial experience of the HeartWare® Ventricular Assist System showed a survival rate of 90 percent at six months and an actuarial survival rate of 86 percent at 12 months post implant.

New blood test for diagnosing schizophrenia to be launched in 2010

A blood test for diagnosing schizophrenia - the most serious form of mental illness - could be available this year, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

Read more Medical News

› Verified 4 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 54
Patient months included in arterial venous fistula and catheter summaries 385
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer

News Archive

EHNAC announces second stage of public review and comment for its HIE Accreditation Program

The Electronic Healthcare Network Accreditation Commission, a non-profit standards development organization and accrediting body, today announced the second stage of public review and comment for its Health Information Exchange Accreditation Program. Compared to the first phase of the program's public review in February, which focused on privacy and security, technical performance, business practices and organizational resources, this second phase will explicitly address HIE-specific policies as developed by the HIE Advisory Board.

Life Technologies second-quarter Non-GAAP revenue increases 8% to $906 million

Life Technologies Corporation today announced results for its second quarter ending June 30, 2010. Non-GAAP revenue for the second quarter was $906 million, an increase of 8 percent over the $839 million reported for the second quarter of 2009. Excluding the impact of currency and prior acquisitions and divestitures, organic revenue for the quarter grew 6 percent over the same period in the previous year.

Olympic gold medal winner Lisa Leslie and Covidien launch new liver cancer education program

Four-time Olympic gold medal winner and three-time WNBA Most Valuable Player Lisa Leslie is teaming with Covidien, a leading global provider of healthcare products, to launch an educational program and Web site, www.MyLiverCancerOptions.com, that provide information to help patients and their families understand the treatment options available to manage liver cancer.

HeartWare International presents clinical trial data of Ventricular Assist System at ISHLT annual meeting

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that data from its international clinical trial and commercial experience of the HeartWare® Ventricular Assist System showed a survival rate of 90 percent at six months and an actuarial survival rate of 86 percent at 12 months post implant.

New blood test for diagnosing schizophrenia to be launched in 2010

A blood test for diagnosing schizophrenia - the most serious form of mental illness - could be available this year, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

Read more Medical News

› Verified 4 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary
Hospitalization Rate in facility (Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit

News Archive

EHNAC announces second stage of public review and comment for its HIE Accreditation Program

The Electronic Healthcare Network Accreditation Commission, a non-profit standards development organization and accrediting body, today announced the second stage of public review and comment for its Health Information Exchange Accreditation Program. Compared to the first phase of the program's public review in February, which focused on privacy and security, technical performance, business practices and organizational resources, this second phase will explicitly address HIE-specific policies as developed by the HIE Advisory Board.

Life Technologies second-quarter Non-GAAP revenue increases 8% to $906 million

Life Technologies Corporation today announced results for its second quarter ending June 30, 2010. Non-GAAP revenue for the second quarter was $906 million, an increase of 8 percent over the $839 million reported for the second quarter of 2009. Excluding the impact of currency and prior acquisitions and divestitures, organic revenue for the quarter grew 6 percent over the same period in the previous year.

Olympic gold medal winner Lisa Leslie and Covidien launch new liver cancer education program

Four-time Olympic gold medal winner and three-time WNBA Most Valuable Player Lisa Leslie is teaming with Covidien, a leading global provider of healthcare products, to launch an educational program and Web site, www.MyLiverCancerOptions.com, that provide information to help patients and their families understand the treatment options available to manage liver cancer.

HeartWare International presents clinical trial data of Ventricular Assist System at ISHLT annual meeting

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that data from its international clinical trial and commercial experience of the HeartWare® Ventricular Assist System showed a survival rate of 90 percent at six months and an actuarial survival rate of 86 percent at 12 months post implant.

New blood test for diagnosing schizophrenia to be launched in 2010

A blood test for diagnosing schizophrenia - the most serious form of mental illness - could be available this year, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

Read more Medical News

› Verified 4 days ago